FDA wraps up cyclospora probe with new plan to “mitigate” risks
The FDA has outlined a ten-point plan to “mitigate” the risks of another cyclospora outbreak as it wrapped up an…
The FDA has outlined a ten-point plan to “mitigate” the risks of another cyclospora outbreak as it wrapped up an…